Share

November 12, 2013; 81 (20) Article

Higher glucose levels associated with lower memory and reduced hippocampal microstructure

Lucia Kerti, A. Veronica Witte, Angela Winkler, Ulrike Grittner, Dan Rujescu, Agnes Flöel
First published October 23, 2013, DOI: https://doi.org/10.1212/01.wnl.0000435561.00234.ee
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1236

Share

Article Information

vol. 81 no. 20 1746-1752
DOI: 
https://doi.org/10.1212/01.wnl.0000435561.00234.ee
PubMed: 
24153444
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 7, 2013
  • Accepted in final form August 14, 2013
  • First Published October 23, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Lucia Kerti, MA*,
    2. A. Veronica Witte, PhD*,
    3. Angela Winkler, MA,
    4. Ulrike Grittner, PhD,
    5. Dan Rujescu, MD and
    6. Agnes Flöel, MD
  1. Lucia Kerti, MA*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German society for neurology, compensation for travel related expenses (conference talks 2010 and 2011)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. A. Veronica Witte, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German Society for Neurology, travel compensations for conference talks, 2010-12, (2) Alzheimer's Association, travel grant for conference talk, 2012, (3) German National Academic Foundation, compensation for educational course, 2012, (4) Sport-Gesundheitspark Berlin e.V., honoraria for a symposium's talk, 2012

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Federal Ministry of Education and Research, FKZ 0315673, Co-PI, 2010-13

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. German Research Foundation, FL 379/8-1, Co-PI, 2009-present

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Angela Winkler, MA,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) German society for neurology, compensation for travel related expenses (conference talk 2012)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ulrike Grittner, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I received funding from the Center for Rusmiddelforskning Aarhus University, Denmark, from the Albrecht-Kossel-Institute for Neuroregeneration Rostock University, Germany and from the Federal Ministry of Education and Research via the Grant Center for Stroke Research Berlin (01 EO 0801).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Dan Rujescu, MD and
    6. Scientific Advisory Boards:

    1. F.Hoffmann-La Roche Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. F.Hoffmann-La Roche Advisory Board

    Editorial Boards:

    1. International Journal of Neuropsychopharmacology (CINP) Field Editor for Molecular Psychiatry of the World Journal of Biological Psychiatry BMC Medical Genetics European Neuropsychopharmacology (ECNP) Suizidprophylaxe European Archives of Psychiatry and Clinical Neuroscience

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Agnes Flöel, MD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Received one-time speaker honoraria (between 500 and 1000 Euro) for oral presentations from Novartis, B?hringer-Ingelheim and Souvenaid (commercial entities). not related to present study

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties from the book ?Alzheimer- Unabwendbares Schicksal?? from 2012 onwards (less than 3000 Euro total) not related to present study

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Received one-time consulting fees from Schwabe (1500 Euro, commercial entity). not related to present study

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Fl 379-8/1, Fl 379-10/1, Fl 279-11/1; and DFG-Exc 257), the Else-Kr?ner Fresenius Stiftung (2009-141 ; 2011-119), and the Bundesministerium f?r Bildung und Forschung (FKZ 0315673A, 01EO0801 and 01GY1144).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (L.K., A.V.W., A.W., A.F.) and Biostatistics and Clinical Epidemiology (U.G.), NeuroCure Cluster of Excellence (A.V.W., A.F.), and Center for Stroke Research Berlin (U.G., A.F.), Charité–University Medicine, Berlin; and Department of Psychiatry (D.R.), University of Halle, Germany.
  1. Correspondence to Dr. Flöel: agnes.floeel{at}charite.de or Ms. Kerti: lucia.kerti{at}charite.de
View Full Text

Article usage

Article usage: October 2013 to May 2019

AbstractFullPdfSource
Oct 201364426177Highwire
Nov 2013589565157Highwire
Dec 20134030282522Highwire
Jan 201418293352Highwire
Feb 20148321624Highwire
Mar 20148111019Highwire
Apr 20146171212Highwire
May 20145671217Highwire
Jun 201453876Highwire
Jul 201410911117Highwire
Aug 2014441911Highwire
Sep 2014586911Highwire
Oct 2014117355Highwire
Nov 201441638Highwire
Dec 2014429711Highwire
Jan 20154351315Highwire
Feb 20153091212Highwire
Mar 201543564Highwire
Apr 201529056Highwire
May 201535413Highwire
Jun 201528577Highwire
Jul 201540368Highwire
Aug 201532265Highwire
Sep 2015381914Highwire
Oct 201545374Highwire
Nov 201529497Highwire
Dec 201527523Highwire
Jan 201635995Highwire
Feb 201630233Highwire
Mar 201637766Highwire
Apr 201628621Highwire
May 201627963Highwire
Jun 201628743Highwire
Jul 201636622Highwire
Aug 201634444Highwire
Sep 201643012Highwire
Oct 201639844Highwire
Nov 201632522Highwire
Dec 201628122Highwire
Jan 2017126300Highwire
Feb 201766501Highwire
Mar 201767535Highwire
Apr 2017110953Highwire
May 2017605107Highwire
Jun 201758003Highwire
Jul 201770635Highwire
Aug 201772412Highwire
Sep 201758742Highwire
Oct 201767832Highwire
Nov 201769810Highwire
Dec 201734122Highwire
Jan 201833711Highwire
Feb 201846575Highwire
Mar 201836586Highwire
Apr 201846042Highwire
May 201836231Highwire
Jun 201828630Highwire
Jul 201830352Highwire
Aug 201825501Highwire
Sep 201828522Highwire
Oct 201832722Highwire
Nov 201839782Highwire
Dec 201841610Highwire
Jan 201945021Highwire
Feb 201934310Highwire
Mar 201931070Highwire
Apr 201941131Highwire
May 201932224Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me